Antidepressant use limits serotonin as a marker for neuroendocrine tumor disease activity by lowering of circulating serotonin concentrations

Huub H. van Rossum*, Jocelyn Spruit, Catharina M. Korse, Froukje E. de Vries, Margot E.T. Tesselaar

*Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Pages (from-to)E241-E243
JournalClinical Chemistry and Laboratory Medicine
Issue number10
Publication statusPublished - 1 Oct 2020

Cite this